Page last updated: 2024-11-13

candidin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID24836139
MeSH IDM0055926

Synonyms (14)

Synonym
candidin
amphotericin b, 8,9-dideoxy-10-hydroxy-7-oxo-
8,9-dideoxy-10-hydroxy-7-oxoamphotericin b
einecs 215-788-3
1405-90-9
1n0j75483y ,
unii-1n0j75483y
amphotericin b, 8,9-dideoxy-10-hydroxy-7-oxo-, (10r)-
candidin [mi]
candidin (streptomyces)
7-oxo-7-deoxy-28,29-didehydronystatin
(10r)-8,9-dideoxy-10-hydroxy-7-oxoamphotericin b
Q27252621
(1s,3r,4r,9s,11r,15s,16r,17r,18s,19e,21e,23e,25e,27e,29e,31e,33r,35s,36r,37s)-33-[(2r,3s,4s,5s,6r)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,4,9,11,17,37-heptahydroxy-15,16,18-trimethyl-7,13-dioxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,

Research Excerpts

Overview

Candidin is a suspension of killed yeast cells. It is commonly used for intradermal tests of delayed hypersensitivity, to evaluate the immunological cellular competence of the patient.

ExcerptReferenceRelevance
"A candidin, which is a suspension of killed yeast cells, is commonly used for intradermal tests of delayed hypersensitivity, to evaluate the immunological cellular competence of the patient, when the test is applied along with other similar tests. "( Candidin: comparison of two antigens for cutaneous delayed hypersensitivity testing.
Croce, J; Fava, Sde C; Fava-Netto, C; Gambale, W; Paula, CR,
)
2.3

Dosage Studied

ExcerptRelevanceReference
"Under study was the effect of oxyprogesterone-capronate (500 mg daily, total dosage of 10 g) on delayed cutaneous hypersensitivity reaction (DCHR) to tuberculin and candidine as well as the level of T-lymphocytes and cortisol in the peripheral blood in 34 patients with primary cancer of the corpus uteri."( [Effect of hydroxyprogesterone caproate on immunological skin tests and on the T-lymphocytes in cancer of the corpus uteri].
Bobrov, IuF; Bokhman, IaV; Kondrat'ev, VB; Krylova, NV; Mar'enko, AI, 1980
)
0.46
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (29)

TimeframeStudies, This Drug (%)All Drugs %
pre-199022 (75.86)18.7374
1990's4 (13.79)18.2507
2000's2 (6.90)29.6817
2010's1 (3.45)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 31.46

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index31.46 (24.57)
Research Supply Index3.66 (2.92)
Research Growth Index4.08 (4.65)
Search Engine Demand Index42.09 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (31.46)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (2.70%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (2.70%)4.05%
Observational0 (0.00%)0.25%
Other35 (94.59%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]